XML 94 R72.htm IDEA: XBRL DOCUMENT v3.25.2
SHARE CAPITAL (Disclosure of stock option and share-based payment activity) (Details)
 12 Months Ended
Mar. 31, 2025
Share
$ / shares
Mar. 31, 2024
Share
$ / shares
Mar. 31, 2023
Share
$ / shares
Number [Abstract]      
Balance, beginning of year 7,098,334    
Exercised (1,700,000) (2,000,000) (2,000,000)
Balance, end of year 6,123,334 7,098,334  
Weighted average exercise price [Abstract]      
Balance, beginning of year | $ / shares $ 2.37    
Balance, end of year | $ / shares $ 2.32 $ 2.37  
Triera Biosciences Ltd [Member]      
Number [Abstract]      
Balance, beginning of year 195,000 0  
Granted 5,000 195,000  
Exercised 0 0  
Expired (10,000) 0  
Balance, end of year 190,000 195,000 0
Weighted average exercise price [Abstract]      
Balance, beginning of year | $ / shares $ 1 $ 0  
Granted | $ / shares 1 1  
Exercised | $ / shares 0 0  
Expired | $ / shares 1 0  
Balance, end of year | $ / shares $ 1 $ 1 $ 0
Stock option and share-based payment activity [Member]      
Number [Abstract]      
Balance, beginning of year 7,098,334 8,673,334  
Granted 2,000,000 1,250,000  
Exercised (1,700,000) (2,000,000)  
Expired (1,275,000) (825,000)  
Balance, end of year 6,123,334 7,098,334 8,673,334
Weighted average exercise price [Abstract]      
Balance, beginning of year | $ / shares $ 2.37 $ 2.03  
Granted | $ / shares 1.52 2.03  
Exercised | $ / shares 0.45 0.54  
Expired | $ / shares 3.84 2.72  
Balance, end of year | $ / shares $ 2.32 $ 2.37 $ 2.03